DXSE:XETRA:XETRA-Xtrackers - Stoxx Europe 600 Health Care Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 236.35

Change

+1.25 (+0.53)%

Market Cap

USD 0.14B

Volume

2.01K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-23 )

ETFs Containing DXSE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.82% 88% B+ 85% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.82% 88% B+ 84% B
Trailing 12 Months  
Capital Gain 15.18% 58% F 61% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.18% 57% F 59% D-
Trailing 5 Years  
Capital Gain 72.27% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.27% 80% B- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 8.61% 70% C- 68% D+
Dividend Return 8.61% 69% C- 66% D+
Total Return N/A 15% F 31% F
Risk Return Profile  
Volatility (Standard Deviation) 8.39% 67% D+ 74% C
Risk Adjusted Return 102.60% 99% N/A 99% N/A
Market Capitalization 0.14B 42% F 38% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.